Abivax SA Director Resigns
Ticker: AAVXF · Form: 6-K · Filed: Dec 23, 2024 · CIK: 1956827
| Field | Detail |
|---|---|
| Company | Abivax S.A. (AAVXF) |
| Form Type | 6-K |
| Filed Date | Dec 23, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-member-change, resignation
TL;DR
Abivax director Pouletty out Dec 31, no drama.
AI Summary
On December 23, 2024, Abivax SA announced that Dr. Philippe Pouletty will resign from its Board of Directors, effective December 31, 2024. This resignation is not due to any disagreements regarding the Company's operations, policies, or practices.
Why It Matters
The departure of a board member, even without disagreement, can signal shifts in company strategy or governance that investors should monitor.
Risk Assessment
Risk Level: low — The filing is a routine announcement of a board member's resignation without any stated disagreements, indicating low immediate risk.
Key Players & Entities
- Abivax SA (company) — Registrant
- Dr. Philippe Pouletty (person) — Resigning Board Member
- December 31, 2024 (date) — Effective date of resignation
- December 23, 2024 (date) — Date of announcement
FAQ
Who is resigning from Abivax SA's Board of Directors?
Dr. Philippe Pouletty is resigning from Abivax SA's Board of Directors.
When is Dr. Philippe Pouletty's resignation effective?
Dr. Philippe Pouletty's resignation is effective on December 31, 2024.
What is the reason for Dr. Pouletty's resignation?
The filing states that Dr. Pouletty's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
On what date did Abivax SA announce this resignation?
Abivax SA announced the resignation on December 23, 2024.
What form is this filing?
This filing is a Form 6-K.
Filing Stats: 249 words · 1 min read · ~1 pages · Grade level 12.3 · Accepted 2024-12-23 17:14:28
Filing Documents
- d891803d6k.htm (6-K) — 9KB
- d891803dex991.htm (EX-99.1) — 9KB
- g891803g1224020503990.jpg (GRAPHIC) — 3KB
- 0001193125-24-284298.txt ( ) — 24KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Abivax SA (Registrant) Date: December 23, 2024 /s/ Marc de Garidel Marc de Garidel Chief Executive Officer